The Goldman Sachs Group, Inc. 13D and 13G filings for BioLife Solutions, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-01 4:19 pm Sale |
2024-09-30 | 13G | BioLife Solutions, Inc. BLFS |
GOLDMAN SACHS GROUP INC GS |
161,488 0.400% |
-2,314,754 (-93.48%) |
Filing |
| 2024-02-02 10:11 am Purchase |
2023-12-29 | 13G | BioLife Solutions, Inc. BLFS |
GOLDMAN SACHS GROUP INC GS |
2,476,242 5.500% |
2,476,242 (New Position) |
Filing |